Covidshield Technologies Private Limited

Covidshield Technologies Private Limited - pharma in Pune, Maharashtra, India. FY 2026 financials & compliance.
CIN U24100PN2019PTC188668 Incorporated 25 December 2019 ROC Pune HQ Pune, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹47.12 Lakh
▲ 14% YoY
Net profit · FY 2025
₹23.33 Lakh
Net margin 49.5%
EBITDA · FY 2025
₹31.62 Lakh
EBITDA margin 67.1%
Authorised capital
₹7.5 Cr
Registered with MCA
Paid-up capital
₹7.5 Cr
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered

About Covidshield Technologies Private Limited

Data last updated:

Covidshield Technologies Private Limited is a private limited company based in Pune, Maharashtra, India, a subsidiary of Serum Institute Life Sciences Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 December 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24100PN2019PTC188668. Its GSTIN is 27AANCM1888N1ZK (Maharashtra).

The company has an authorised share capital of ₹7.5 Cr and a paid-up capital of ₹7.5 Cr. It was formerly known as Manjri Technologies Private Limited. It is led by directors including Tushar Vijay Modak and Vijay Chandrakant Bharate.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No.401 4th Floor Sarosh Bhavan 16 – B/1 Dr. Ambedkar Road, Pune, Maharashtra, India – 411001.

As per the financials filed for FY 2025, the company reported a revenue of ₹47.12 Lakh, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹23.33 Lakh (net margin 49.5%) and EBITDA of ₹31.62 Lakh (EBITDA margin 67.1%). Revenue has grown at a compounded annual rate (CAGR) of 41% over three years.

The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹7.49 Cr; the latest was in September 2021.

For more details, the company can be reached via its website seruminstitute.com.

Company Details of Covidshield Technologies Private Limited
CIN U24100PN2019PTC188668
Registration Number 188668
Incorporation Date 25 December 2019
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Serum Institute Life Sciences Private Limited
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    Office No.401 4th Floor Sarosh Bhavan 16 – B/1 Dr. Ambedkar Road, Pune, Maharashtra, India – 411001
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Covidshield Technologies Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Covidshield Technologies Private Limited report

Financials, compliance, directors, charges, ownership and filings for Covidshield Technologies Private Limited in one report.

Financials from FY 2020 Directors & ownership Charges & compliance

Financials of Covidshield Technologies Private Limited FY 2025 filings available

Covidshield Technologies Private Limited reported revenue of ₹47.12 Lakh (up 14% YoY) for FY 2025.

Revenue · FY 2025
₹47.12 Lakh ▲ 14%
Net profit · FY 2025
₹23.33 Lakh margin 49.5%
EBITDA · FY 2025
₹31.62 Lakh margin 67.1%

Compounded Annual Growth Rate (CAGR) of Covidshield Technologies Private Limited

Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 41%
EBITDA CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 54%
5 years · compounded
▲ 213%

Revenue has grown at a compounded annual rate (CAGR) of 41% over three years, including 14% growth in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Covidshield Technologies Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹31.62 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹23.33 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Covidshield Technologies Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin67.1%••••••••••••••••
Net Profit Margin49.5%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Covidshield Technologies are in the company report.

Premium access

Financial statements from FY 2020

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Auditor Details of Covidshield Technologies Private Limited

Covidshield Technologies Private Limited is audited by PATKI AND SOMAN for the financial year 2023.

NameStatusAppointment DateCessation Date
PATKI AND SOMANLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Covidshield Technologies Private Limited

Covidshield Technologies has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Tushar Vijay ModakDirector25 Dec 20196 Years 9 MonthsCurrent
Vijay Chandrakant BharateDirector05 Oct 20242 Years 0 MonthsCurrent
Narendra Gajanan WadadekarDirector05 Oct 20242 Years 0 MonthsCurrent
Adar Cyrus PoonawallaDirector28 Apr 20215 Years 5 MonthsCurrent

Ownership and Shareholding of Covidshield Technologies Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Covidshield Technologies Private Limited

Covidshield Technologies Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Deals & Funding of Covidshield Technologies Private Limited

Covidshield Technologies Private Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹7.49 Cr; the latest was in September 2021.

Total deals
3
Secondary share transfers
2
Funding round
1
Disclosed funding
₹7.49 Cr

Deals on record (3 of 3)

WhenDealAmountParties
Sep 2021Funding round₹7.49 CrInvestors: Serum Institute Life Sciences Private Limited
Jul 2021Secondary share transferUndisclosedBuyer: Serum Institute Life Sciences Private Limited , Serum Institute Life Sciences Private Limited & Saurabh Lakshman Prabhudesai
Seller: Poonawala Family Office, an individual
Mar 2021Secondary share transferUndisclosedBuyer: Poonawala Family Office, an individual
Seller: 2 individuals
Premium access

Full deal history

All 3 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Employees and EPFO Compliance at Covidshield Technologies Private Limited

Employment history and EPFO contributions of people linked to Covidshield Technologies.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

CIN History of Covidshield Technologies Private Limited

Covidshield Technologies has one previous CIN (Corporate Identification Number): U72900PN2019PTC188668. The current CIN is U24100PN2019PTC188668, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24100PN2019PTC188668Current
U72900PN2019PTC188668Previous

Recent Activity on Covidshield Technologies Private Limited

Covidshield Technologies Private Limited has 8 board changes on record since 2019: 4 appointments and 4 cessations. The latest: Narendra Gajanan Wadadekar ceased to be Additional Director on 28 Sep 2025.

AGM
Covidshield Technologies Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Ceased
Narendra Gajanan Wadadekar ceased to be Additional Director.
Ceased
Vijay Chandrakant Bharate ceased to be Additional Director.
Filing
Covidshield Technologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Appointed
Narendra Gajanan Wadadekar was appointed as Director.
Ceased
Saurabh Lakshman Prabhudesai ceased to be Director.
Appointed
Vijay Chandrakant Bharate was appointed as Director.
Ceased
Adar Cyrus Poonawalla ceased to be Additional Director.
Appointed
Adar Cyrus Poonawalla was appointed as Director.
Appointed
Tushar Vijay Modak was appointed as Director.
Incorporation
25 Dec 2019
Covidshield Technologies Private Limited was registered on 25 Dec 2019 with Roc Pune & aged 6 years 9 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Covidshield Technologies Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Covidshield Technologies Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Covidshield Technologies Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Covidshield Technologies Private Limited

Covidshield Technologies has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AANCM1888N1ZKMaharashtraActive25 Dec 2021
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Covidshield Technologies Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Covidshield Technologies Private Limited

Covidshield Technologies is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 December 2019 (7+ years old) and is registered under CIN U24100PN2019PTC188668.

Covidshield Technologies reported revenue of ₹47.12 Lakh for FY 2025 (up 14% YoY).

Covidshield Technologies has 4 current directors:

Covidshield Technologies reported a net profit of ₹23.33 Lakh (net margin 49.5%) and EBITDA of ₹31.62 Lakh (EBITDA margin 67.1%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Covidshield Technologies is 41% over three years. In the latest year (FY 2025) revenue rose 14%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Covidshield Technologies is 27AANCM1888N1ZK, registered in Maharashtra.

The CIN (Corporate Identification Number) of Covidshield Technologies is U24100PN2019PTC188668. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Covidshield Technologies was incorporated on 25 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Pune.

Covidshield Technologies has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹7.49 Cr; the latest was in September 2021.

Narendra Gajanan Wadadekar ceased to be Additional Director on 28 Sep 2025. Vijay Chandrakant Bharate ceased to be Additional Director on 28 Sep 2025. Narendra Gajanan Wadadekar was appointed as Director on 05 Oct 2024. Covidshield Technologies has 8 board changes on record in total.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available